- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Sectors
Motif FoodWorks makes $226m series B move
Motif FoodWorks, launched by Gingko Bioworks, has pocketed $226m in a round backed by returning investor Louis Dreyfus a month after Gingko agreed to a reverse merger.
Jun 17, 2021Umoja draws on SoftBank for $210m
SoftBank Vision Fund 2 co-led a series B round for immunotherapy developer Umoja Biopharma with Cormorant Asset Management.
Jun 17, 2021Guideline gathers $200m
Propel Venture Partners has helped the retirement plan provider increase its overall funding to $344m by investing in a round led by General Atlantic.
Jun 17, 2021Xiaoetong turns to series D for $120m
The Tencent and TAL Education-backed business management platform developer received the capital from IDG Capital, Hillhouse Capital, GGV Capital and Qiming Venture Partners.
Jun 17, 2021Addepar absorbs $150m in series F funding
The CreditEase-backed wealth management software provider was valued at $2bn after securing investment from D1 Capital Partners.
Jun 17, 2021Umoja draws on SoftBank for $210m
Umoja Biopharma, based on research at Purdue University and Seattle Children’s Research Institute, has picked up a series B co-led by SoftBank Vision Fund 2.
Jun 17, 2021Motif makes $226m series B move
Motif FoodWorks, which traces its roots to MIT, has pocketed $226m in a round backed by returning investor Louis Dreyfus a month after Motif’s parent agreed to a reverse merger.
Jun 17, 2021Uberall undertakes $115m series C
The marketing platform developer is using cash from the United Internet-backed round to acquire MomentFeed, a deal that will allow Rockfish to exit.
Jun 17, 2021G2 Venture Partners closes $500m Fund II
Shell Ventures has re-upped in G2 Venture Partners’ sophomore fund, which was also backed by Mitsui, Daimler and ABB Switzerland.
Jun 17, 2021Apollo assembles investors for $145m round
The Johnson & Johnson, GSK and AstraZeneca-backed drug developer raised the cash in a Patient Square Capital-led round that took its total funding beyond $200m.
Jun 17, 2021Heliogen heats up with $108m
The CSP technology developer revealed two new funding rounds including an $83m bridge round backed by ArcelorMittal and Edison International.
Jun 17, 2021The Pill Club swallows more series B funds
GV has participated in a $41.9m series B extension for the birth control delivery service, which increased the round's size to $92.9m.
Jun 17, 2021Featured Content
The CVC Funding Round DatabaseRealtime data of all startup funding rounds with corporate backers. Full access for GCV+ subscribers.The CVC Funding Round Database
Realtime data of all startup funding rounds with corporate backers. Full access for GCV+ subscribers.
CVC DirectoryFull details of 600+ CVC units globally, including key people, sector focus, preferred investment stage and more. ull access for GCV+ subscribers.CVC Directory
Full details of 600+ CVC units globally, including key people, sector focus, preferred investment stage and more. ull access for GCV+ subscribers.
Corporate venture building reportData from 100+ corporate venture building programmes, including size, budgets, staffing, reporting lines and outcomesCorporate venture building report
Data from 100+ corporate venture building programmes, including size, budgets, staffing, reporting lines and outcomes
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
